Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
Corvus Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 168 institutions reported holding Corvus Pharmaceuticals, Inc., 84.1% of its shares. Largest: Orbimed Advisors LLC, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Corvus Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Orbimed Advisors LLC | 7.17M | 8.5% | no change | Aug 14, 2026 |
| BlackRock | 7.14M | 8.5% | +978K | Aug 7, 2026 |
| Vanguard | 4.74M | 5.6% | +279K | Aug 13, 2026 |
| State Street | 4.47M | 5.3% | +908K | Aug 7, 2026 |
| T. Rowe Price | 3.79M | 4.5% | +872K | Aug 14, 2026 |
| Adams Street Partners LLC | 3.28M | 3.9% | no change | Aug 14, 2026 |
| Vivo Capital, LLC | 2.81M | 3.3% | no change | Aug 14, 2026 |
| Wellington | 2.73M | 3.2% | +413K | Aug 14, 2026 |
| Perceptive Advisors LLC | 2.67M | 3.2% | +375K | Aug 14, 2026 |
| Deep Track Capital, LP | 2.49M | 3.0% | +400 | Aug 14, 2026 |